Changes in liver surgery for colorectal cancer liver metastases under neoadjuvant treatment strategies

European Surgery - Acta Chirurgica Austriaca

Volumn 36, Issue 5, 2004, Pages 317-321

  Gruenberger, T ^a   Schuell, B ^a   Puhalla, H ^a   Schwanzer, E ^a   Bodingbauer, M ^a   Laengle, F ^a   Kornek, G ^a   Scheithauer, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Colorectal cancer liver metastases; Interdisciplinary meeting; Liver surgery; Neoadjuvant chemotherapy; Secondary resectability

Indexed keywords

ADJUVANT THERAPY; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COLORECTAL CANCER; FEMALE; HUMAN; LIFE EXPECTANCY; LIVER METASTASIS; LIVER RESECTION; LIVER SURGERY; MEDICAL LITERATURE;

EID: 14344256026     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10353-004-0095-2     Document Type: Article

References (46)

1. Kondo S, Hirano S, Ambo Y, Tanaka E, Okushiba S, Morikawa T, Katoh H (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240: 95-101
2. Kooby D, Stockman J, Ben-Porat L, Gonen M, Jarnagin W, Dematteo R, Tuorto S, Wuest D, Blumgart L, Fong Y (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237: 860-870
3. Melendez J, Arslan V, Fischer M, Wuest D, Jarnagin W, Fong Y, Blumgart L (1998) Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and risk of postoperative renal dysfunction. J Am Coll Surg 187: 620-625
4. Vauthey J, Pawlik T, Abdalla E, Arens J, Nemr R, Wei S, Kennamer D, Ellis L, Curley S (2004) Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239: 722-732
5. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318; discussion 318-321
6. Dimick J, Wainess R, Cowan J, Upchurch G Jr, Knol J, Colletti L (2004) National trends in the use and outcomes of hepatic resection. J Am Coll Surg 199: 31-38
7. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, Vellone M, Giuliante F, Nuzzo G, Barone C (2004) Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15: 933-939
8. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8: 347-353
9. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR (2004) A randomized controlled trial of fluorouracil plus leucovorin, Irinotecan, and Oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23-30
10. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229-237
11. Tanaka K, Adam R, Shimada H, Azoulay D, Levi F, Bismuth H (2003) Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90: 963-969
12. Yamamoto Y, Ikai I, Kume M, Sakai Y, Yamauchi A, Shinohara H, Morimoto T, Shimahara Y, Yamamoto M, Yamaoko Y (1999) New simple technique for hepatic parenchymal resection using a Cavitron ultrasonic surgical aspirator and bipolar cautery equipped with a channel for water dripping. World J Surg 23: 1032-1037
13. Rau HG, Schauer R, Pickelmann S, Beyer BC, Angele MK, Zimmermann A, Meimarakis G, Heizmann O, Schildberg FW (2001) Dissection techniques in liver surgery. Chirurg 72: 105-112
14. Topp S, McClurken M, Lipson D, Upadhya G, Ritter J, Linehan D, Strasberg S (2004) Saline-linked surface radiofrequency ablation: factors affecting steam popping and depth of injury in the pig liver. Ann Surg 239: 518-527
15. Sakamoto Y, Yamamoto J, Kokudo N, Seki M, Kosuge T, Yamaguchi T, Muto T, Makuuchi M (2004) Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections. World J Surg 28: 166-172
16. Heriot A, Karanija N (2002) A review of techniques for liver resection. Ann R Coll Surg Engl 84: 371-380
17. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, Takayama T, Makuuchi M (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138: 1198-1206
18. Altendorf-Hofmann A, Scheele J (2003) A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12: 165-192
19. Elias D, Sideris L, Pocard M, Ouellet J, Boige V, Lasser P, Pignon J, Ducreux M (2004) Results of RO resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 11: 274-280
20. Gruenberger T (2002) Alternative regional treatment of resectable and unresectable liver metastases. Eur Surg 34: 337-340
21. Abdalla E, Vauthey J, Ellis L, Ellis V, Pollock R, Broglio K, Hess K, Curley S (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: 818-827
22. Vogl TJ, Straub R, Eichler K, Sollner O, Mack MG (2004) Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 230: 450-458
23. Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP (2003) The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer 39: 2150-2164
24. Seifert J, Junginger T, Morris D (1998) A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb 43: 141-154
25. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, Lemoine A, Bismuth H (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231: 480-486
26. Hemming A, Reed A, Howard R, Fujita S, Hochwald S, Caridi J, Hawkins I, Vauthey J (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237: 686-693
27. Jaeck D, Bachellier P, Nakano H, Oussoultzoglou E, Weber J-C, Wolf P, Greget M (2003) One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185: 221-229
28. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232: 777-785
29. Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, Encke A, Blumgart L, Fong Y (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235: 863-871
30. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238: 871-884
31. Reimer P, Jahnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N, Saini S (2000) Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217: 152-158
32. Gruenberger T, Jourdan JL, Zhao J, King J, Morris DL (2000) Echogenicity of liver metastases is an independent prognostic factor after potentially curative treatment. Arch Surg 135: 1285-1290
33. Sojar V, Stanisavljevic D, Hribernik M, Fius T, Kreuh D, Velkavrh U (2004) Liver surgery planning in 3D virtual space. HPB 6 Suppl 1: 179
34. Wagman L, Kemency M, Leong L, Terz J, Hill L, Beatty J, Kokal W, Riihimaki D (1990) A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8: 1885-1893
35. Imamura H, Seyama Y, Kokudo N, Aoki T, Sano K, Minagawa M, Sugawara Y, Makuuchi M (2004) Single and multiple resections of multiple hepatic metastases of colorectal origin. Surgery 135: 508-517
36. Grothey A, Sargent D, Goldberg RM, Schmoll H-J (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, Irinotecan, and Oxaliplatin in the course of treatment. J Clin Oncol 22: 1209-1214
37. Lorenz M, Mueller H, Schramm H, Gassel H, Rau H, Ridwelski K, Hauss J, Stieger R, Jauch K, Bechstein W, Encke A (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folonic acid for liver metastases of colorectal cancer. Ann Surg 228: 756-762
38. Adam R, Pascal G, Castaing D, Azoulay D, Paule B, Levi F, Bismuth H (2003) Liver resection for multiple colorectal metastases: influence of preoperative chemotherapy. Proc Am Soc Clin Oncol 22: abstract 1188
39. Gruenberger T, Schuell B, Kornek G, Scheithauer W (2004) Neoadjuvant chemotherapy for resectable colorectal cancer liver metastases: impact on magnitude of liver resection and survival. Proc Am Soc Clin Oncol 23: 270 (abstract 3598)
40. Douillard J-Y, Sobrero A, Carnaghi C, Cornelia P, Diaz-Rubio E, Santoro A, Van Cutsem E (2003) Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy. Ann Oncol 14 Suppl 2: 7ii-12
41. Scheithauer W, Kornek GV, Raderer M, Schull B, Schmid K, Kovats E, Schneeweiss B, Lang F, Lenauer A, Depisch D (2003) Randomized multicenter phase II trial of two different schedules of capecitabine plus Oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 21: 1307-1312
42. Fisher G, Kuo D, Cho C, Halsey J, Jambalos C, Schwartz E, Robert R, Advani R, Wakelee H (2004) A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol 23: 249 (abstract 3514)
43. Tabernero J, Van Cutsem E, Sastre J, Cervantes A, Van Laethem J, Humblet Y, Soulié P, Corretgé S, Mueser S, De Gramont A (2004) An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with metastatic colorectal cancer (CRC) expressing epidermal growth factor receptor (EGFR). preliminary results. Proc Am Soc Clin Oncol 23: 248 (abstract 3512)
44. Quenet F, Nordlinger B, Rivoire M, Delpero J, Portier G, Mery-Mignard D, Magherini E, Payrard S, Ychou M (2004) Resection of previously unresectable liver metastases from colorectal cancer (LMCRC) after chemotherapy (CT) with CPT-11/L-OHP/LV5FU (Folfirinox): a prospective phase II trial. Proc Am Soc Clin Oncol 23: 273 (abstract 3613)
45. Falcone A, Masi G, Cupini S, Marcucci L, Ricci L, Brunetti I, Cerri E, Fontana E, Andreuccetti M, Allegrini G (2004) Surgical resection of metastases (mts) after biweekly chemotherapy with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI) in initially unresectable metastatic colorectal cancer (MCRC). Proc Am Soc Clin Oncol 23: 3550 (abstract 3553)
46. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466